Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hai-Feng Pan

Showing results (21-30 of 482) with videos related to

Pageof 49
Sort By:
Arthritis and Rheumatism|July 1, 2010
1,25-Dihydroxyvitamin D(3) may be insufficient to prevent corticosteroid-induced osteoporosis in patients with early rheumatoid arthritis: comment on the article by Colin et alRui-Xue Leng, Hai-Feng Pan, Dong-Qing Ye
Expert Opinion on Therapeutic Targets|March 31, 2010
Therapeutic potential of IL-27 in systemic lupus erythematosusHai-Feng Pan, Jin-Hui Tao, Dong-Qing Ye
Nature Clinical Practice. Rheumatology|May 15, 2008
Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosusHai Feng Pan, Dong Qing Ye, Xiang Pei Li
Inflammopharmacology|October 17, 2019
Therapeutic potential of aryl hydrocarbon receptor in autoimmunityXiao-Song Wang, Fan Cao, Yi Zhang, et al.
Rheumatology International|December 6, 2013
New evidence for roles of growth arrest-specific protein 6 (Gas6) in systemic lupus erythematosusGuo Tian, Jiao-Long Li, Hai-Feng Pan, et al.
Current Pharmaceutical Design|December 17, 2019
Natural Products: Experimental Efficient Agents for Inflammatory Bowel Disease TherapyFan Cao, Jie Liu, Bing-Xian Sha, et al.
Acta Pharmaceutica Sinica. B|September 2, 2024
Progranulin: A promising biomarker and therapeutic target for fibrotic diseasesFan Yang, Ming-Han Cheng, Hai-Feng Pan, et al.
Frontiers in Immunology|March 22, 2024
Editorial: Pathogenetic mechanism and therapeutic target for inflammation in autoimmune diseaseJia Li, Minrui Liang, Hai-Feng Pan, et al.
The Journal of Headache and Pain|May 6, 2025
Unveiling new insights into migraine risk stratification using machine learning models of adjustable risk factorsYu-Chen Liu, Ye-Hai Liu, Hai-Feng Pan, et al.
Rheumatology International|December 22, 2016
The prevalence and risk factors for serositis in patients with systemic lupus erythematosus: a cross-sectional studyYan Liang, Rui-Xue Leng, Hai-Feng Pan, et al.
Pageof 49

Showing results (21-30 of 482) with videos related to

Sort By:
Pageof 49
Arthritis and Rheumatism|July 1, 2010
1,25-Dihydroxyvitamin D(3) may be insufficient to prevent corticosteroid-induced osteoporosis in patients with early rheumatoid arthritis: comment on the article by Colin et alRui-Xue Leng, Hai-Feng Pan, Dong-Qing Ye
Expert Opinion on Therapeutic Targets|March 31, 2010
Therapeutic potential of IL-27 in systemic lupus erythematosusHai-Feng Pan, Jin-Hui Tao, Dong-Qing Ye
Nature Clinical Practice. Rheumatology|May 15, 2008
Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosusHai Feng Pan, Dong Qing Ye, Xiang Pei Li
Inflammopharmacology|October 17, 2019
Therapeutic potential of aryl hydrocarbon receptor in autoimmunityXiao-Song Wang, Fan Cao, Yi Zhang, et al.
Rheumatology International|December 6, 2013
New evidence for roles of growth arrest-specific protein 6 (Gas6) in systemic lupus erythematosusGuo Tian, Jiao-Long Li, Hai-Feng Pan, et al.
Current Pharmaceutical Design|December 17, 2019
Natural Products: Experimental Efficient Agents for Inflammatory Bowel Disease TherapyFan Cao, Jie Liu, Bing-Xian Sha, et al.
Acta Pharmaceutica Sinica. B|September 2, 2024
Progranulin: A promising biomarker and therapeutic target for fibrotic diseasesFan Yang, Ming-Han Cheng, Hai-Feng Pan, et al.
Frontiers in Immunology|March 22, 2024
Editorial: Pathogenetic mechanism and therapeutic target for inflammation in autoimmune diseaseJia Li, Minrui Liang, Hai-Feng Pan, et al.
The Journal of Headache and Pain|May 6, 2025
Unveiling new insights into migraine risk stratification using machine learning models of adjustable risk factorsYu-Chen Liu, Ye-Hai Liu, Hai-Feng Pan, et al.
Rheumatology International|December 22, 2016
The prevalence and risk factors for serositis in patients with systemic lupus erythematosus: a cross-sectional studyYan Liang, Rui-Xue Leng, Hai-Feng Pan, et al.
Pageof 49